To investigate the potential of IL‐10 delivery via ADSCs to promote myofibroblast regression in vitro, we evaluated the changes in α‐smooth muscle actin (α‐SMA) and TGF‐β1 expression in human keloid‐derived fibroblasts. This evidence concerns the gene TGFB1 and keloid.